Table 3.
Subanalysis Based on Practice Location
| Variable | Arizona | Florida | Minnesota | P Value |
|---|---|---|---|---|
| Experience, n (%) | 0.618 | |||
| Fellow | 6 (37.5) | 3 (23.1) | 18 (37.5) | |
| Attending | 10 (62.5) | 10 (76.9) | 30 (62.5) | |
| Subspecialty, n (%) | 0.288 | |||
| General/noninterventional | 7 (43.8) | 8 (61.5) | 16 (33.3) | |
| Imaging | 4 (25.0) | 1 (7.7) | 11 (22.9) | |
| Interventional | 2 (12.5) | 1 (7.7) | 5 (10.4) | |
| Heart failure/transplant | 1 (6.3) | 2 (15.4) | 5 (10.4) | |
| Critical care | 0 (0) | 0 (0) | 4 (8.3) | |
| Electrophysiology | 2 (12.5) | 1 (7.7) | 3 (6.3) | |
| Other | 0 (0) | 0 (0) | 4 (8.3) | |
| Sex, n (%) | 0.066 | |||
| M | 1 (6.3) | 1 (7.7) | 14 (29.2) | |
| F | 15 (93.8) | 12 (92.3) | 34 (70.8) | |
| In a patient age <60 without CKD or DM WITHOUT a past history of hypertension, at which SYSTOLIC BP would you initiate therapy? (mm Hg) | 141.9 (81.3a) | 140.8 (76.9a) | 142.9 (77.1a) | 0.423 |
| In a patient age <60 without CKD or DM WITHOUT a past history of hypertension, at which DIASTOLIC BP would you initiate therapy? (mm Hg) | 91.3 (87.5a) | 90.8 (92.3a) | 92.5 (70.8a) | 0.34 |
| In a patient age >18 with either CKD or DM, at what SYSTOLIC BP would you initiate therapy? (mm Hg) | 136.3 (68.8a ) | 136.2 (69.2a) | 136.0 (43.8a) | 0.994 |
| In a patient age >18 with either CKD or DM, at what DIASTOLIC BP would you initiate therapy? (mm Hg) | 88.9 (62.5a ) | 90.0 (84.6a) | 89.2 (54.2a) | 0.892 |
| In a patient age >60 without CKD or DM, WITHOUT a past history of hypertension, at which SYSTOLIC BP would you initiate therapy? (mm Hg) | 147.5 (50a) | 144.6 (30.8a) | 147.3 (50a) | 0.436 |
| In a patient age >60 without CKD or DM, WITHOUT a past history of hypertension, at which DIASTOLIC BP would you initiate therapy? (mm Hg) | 92.5 (75a) | 90.8 (92.3a) | 92.9 (70.8a) | 0.289 |
| In a patient age <60 without CKD or DM on active treatment for hypertension, what SYSTOLIC BP goal would you aim for? (mm Hg) | 135.0 (56.3a) | 130.8 (30.8a) | 132.7 (45.8a) | 0.324 |
| In a patient age <60 without CKD or DM on active treatment for hypertension, what DIASTOLIC BP goal would you aim for? (mm Hg) | 85.6 (56.3a) | 81.5 (30.8a) | 84.0 (41.7a) | 0.154 |
| In a patient age >60 without CKD or DM on active treatment for hypertension, what SYSTOLIC BP goal would you aim for? (mm Hg) | 141.3 (31.3a) | 136.9 (30.8a) | 138.3 (16.7a) | 0.389 |
| In a patient age >60 without CKD or DM on active treatment for hypertension, what DIASTOLIC BP goal would you aim for? (mm Hg) | 88.1 (68.8a) | 84.6 (46.2a) | 86.3 (62.5a) | 0.18 |
| In an asymptomatic non–African American patient without CAD risk factors, which of the following medication options would you use for initial therapy? n (%) | Diuretic, 13 (81.3); ACEI, 8 (50); angiotensin ant, 3 (18.8); BB, 0 (0); CCB, 4 (25); vasodilator, 0 (0); other, 0 (0) | Diuretic, 6 (46.2); ACEI, 8 (61.5); angiotensin ant, 4 (30.8); BB, 0 (0); CCB, 3 (23.1); vasodilator, 0 (0); other, 1 (7.7) | Diuretic, 27 (56.3); ACEI, 18 (37.5); angiotensin ant, 5 (10.4); BB, 1 (2.1); CCB, 8 (16.7); vasodilator, 0 (0); other, 2 (4.2) | 0.553 |
| In an asymptomatic African American patient without CAD risk factors, which of the following medication options would you use for initial therapy? n (%) | Diuretic, 14 (87.5); ACEI, 1 (6.3); angiotensin ant, 0 (0); BB, 0 (0); CCB, 7 (43.8); vasodilator, 0 (0); other, 0 (0) | Diuretic, 7 (53.8); ACEI, 2 (15.4); angiotensin ant, 1 (7.7); BB, 0 (0); CCB, 6 (46.2); vasodilator, 1 (7.7); other, 1 (7.7) | Diuretic, 22 (45.8); ACEI, 8 (16.7); angiotensin ant, 3 (6.3); BB, 2 (4.2); CCB, 18 (37.5); vasodilator, 4 (8.3); other, 2 (4.2) | 0.266 |
| In an asymptomatic patient with a history of kidney disease, which of the following medication options would you use for initial therapy? n (%) | Diuretic, 1 (6.3); ACEI, 16 (100); angiotensin ant, 3 (18.8); BB, 0 (0); CCB, 1 (6.3); vasodilator, 0 (0); other, 0 (0) | Diuretic, 2 (15.4); ACEI, 10 (76.9); angiotensin ant, 3 (23.1); BB, 0 (0); CCB, 2 (15.4); vasodilator, 0 (0); other, 1 (7.7) | Diuretic, 1 (2.1); ACEI, 42 (87.5); angiotensin ant, 5 (10.4); BB, 0 (0); CCB, 3 (6.3); vasodilator, 1 (2.1); other, 2 (4.2) | 0.542 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; angiotensin ant, angiotensin antagonist; BB, β‐blocker; BP, blood pressure; CAD, coronary artery disease; CCB, calcium channel blocker; CKD, chronic kidney disease; DM, diabetes mellitus; F, female; M, male.
a
Percentage of respondents that selected the BP value recommended by the panelists.